Evidence map›Paper›PMID 33216750›Full record

ArticlePLoS genetics2020

Rare genetic variation at transcription factor binding sites modulates local DNA methylation profiles.

Alejandro Martin-Trujillo, Nihir Patel, Felix Richter, Bharati Jadhav, Paras Garg, Sarah U Morton, David M McKean, Steven R DePalma, Elizabeth Goldmuntz, Dorota Gruber and 11 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 13 institutions in 2 countries.

Alejandro Martin-TrujilloThe Mindich Child Health and Development Institute and Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.ORCID 0000-0003-1089-3941
Nihir PatelThe Mindich Child Health and Development Institute and Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.ORCID 0000-0002-4253-3097
Felix RichterThe Mindich Child Health and Development Institute and Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.ORCID 0000-0003-3429-9621
Bharati JadhavThe Mindich Child Health and Development Institute and Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Paras GargThe Mindich Child Health and Development Institute and Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.ORCID 0000-0002-7128-1124
Sarah U MortonDepartment of Newborn Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0002-7816-2646
David M McKeanDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0001-9023-7666
Steven R DePalmaDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0002-0381-5016
Elizabeth GoldmuntzDivision of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Dorota GruberDepartment of Pediatrics, Cohen Children's Medical Center, Northwell Health, New Hyde Park, NY, Unites States of America.ORCID 0000-0001-5806-0127
Richard KimDepartment of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Jane W NewburgerDepartment of Cardiology, Boston Children's Hospital, Boston, Massachusetts, United States of America.
George A PorterDepartment of Pediatrics, University of Rochester Medical Center, Rochester, NY, United States of America.ORCID 0000-0003-0726-9988
Alessandro GiardiniCardiothoracic Unit, Great Ormond Street Hospital, London, England.
Daniel BernsteinDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, United States of America.
Martin Tristani-FirouziDepartment of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States of America.ORCID 0000-0001-5916-442X
Jonathan G SeidmanDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
Christine E SeidmanDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0001-6380-1209
Wendy K ChungDepartments of Pediatrics and Medicine, Columbia University, New York, NY, United States of America.ORCID 0000-0003-3438-5685
Bruce D GelbThe Mindich Child Health and Development Institute and Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.ORCID 0000-0001-8527-5027
Andrew J SharpThe Mindich Child Health and Development Institute and Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.ORCID 0000-0003-1415-5129
Child Health and Development Institute · USBoston Children's Hospital · USBrigham and Women's Hospital · USChildren's Hospital of Philadelphia · USColumbia University · USGreat Ormond Street Hospital · GBHarvard University · USHoward Hughes Medical Institute · USNorthwell Health · USStanford University · USUniversity of Rochester Medical Center · USUniversity of Southern California · USUniversity of Utah · US

Funding

Pilot investigation of tandem repeat variation as a cause of Alzheimer's disease using whole genome sequencing dataR01NS105781 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SHARP, ANDREW JAMES · 2018 to 2022
$3.6M
Bridging the Gap between Genomics and Clinical Outcomes in CHDUM1HL128711 · NHLBI · UNIVERSITY OF UTAH · PI TRISTANI-FIROUZI, MARTIN, YANDELL, MARK DOUGLAS · 2015 to 2019
$2.0M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
NHLBI NIH HHS UM1 HL128711NIH HHS S10 OD026880NINDS NIH HHS R01 NS105781
6 · The paper itself

Abstract

Although DNA methylation is the best characterized epigenetic mark, the mechanism by which it is targeted to specific regions in the genome remains unclear. Recent studies have revealed that local DNA methylation profiles might be dictated by cis-regulatory DNA sequences that mainly operate via DNA-binding factors. Consistent with this finding, we have recently shown that disruption of CTCF-binding sites by rare single nucleotide variants (SNVs) can underlie cis-linked DNA methylation changes in patients with congenital anomalies. These data raise the hypothesis that rare genetic variation at transcription factor binding sites (TFBSs) might contribute to local DNA methylation patterning. In this work, by combining blood genome-wide DNA methylation profiles, whole genome sequencing-derived SNVs from 247 unrelated individuals along with 133 predicted TFBS motifs derived from ENCODE ChIP-Seq data, we observed an association between the disruption of binding sites for multiple TFs by rare SNVs and extreme DNA methylation values at both local and, to a lesser extent, distant CpGs. While the majority of these changes affected only single CpGs, 24% were associated with multiple outlier CpGs within ±1kb of the disrupted TFBS. Interestingly, disruption of functionally constrained sites within TF motifs lead to larger DNA methylation changes at nearby CpG sites. Altogether, these findings suggest that rare SNVs at TFBS negatively influence TF-DNA binding, which can lead to an altered local DNA methylation profile. Furthermore, subsequent integration of DNA methylation and RNA-Seq profiles from cardiac tissues enabled us to observe an association between rare SNV-directed DNA methylation and outlier expression of nearby genes. In conclusion, our findings not only provide insights into the effect of rare genetic variation at TFBS on shaping local DNA methylation and its consequences on genome regulation, but also provide a rationale to incorporate DNA methylation data to interpret the functional role of rare variants.

Indexed as

DNA MethylationEpigenesis, GeneticAdolescentAdultBinding SitesChildChild, PreschoolChromatin Immunoprecipitation SequencingCohort StudiesCpG IslandsFemaleGenome, HumanHeart Defects, CongenitalHumansInfantInfant, NewbornTranscription Factors

Identifiers

PMID33216750
PMCPMC7679001
OpenAlexW3104533492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.